Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Free Cash Flow (2023 - 2025)

Metagenomi (MGX) has disclosed Free Cash Flow for 3 consecutive years, with -$23.6 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 18.85% to -$23.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$89.5 million through Dec 2025, up 20.25% year-over-year, with the annual reading at -$89.5 million for FY2025, 20.25% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$23.6 million at Metagenomi, down from -$21.3 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$21.3 million in Q3 2025, with the low at -$30.3 million in Q1 2024.
  • Average Free Cash Flow over 3 years is -$25.2 million, with a median of -$24.5 million recorded in 2024.
  • The sharpest move saw Free Cash Flow tumbled 35.0% in 2024, then grew 23.58% in 2025.
  • Over 3 years, Free Cash Flow stood at -$29.5 million in 2023, then rose by 1.39% to -$29.1 million in 2024, then grew by 18.85% to -$23.6 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$23.6 million, -$21.3 million, and -$21.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.